Hiromitsu Negoro
Papers
6
Total Citations
23
H-Index
3
About
Hiromitsu Negoro is a leading urologic surgeon and researcher whose work is redefining the surgical management of prostate cancer, particularly through the lens of robot-assisted radical prostatectomy (RARP). His research focuses on optimizing patient outcomes by meticulously analyzing the impact of patient-specific factors and surgical techniques on postoperative complications and oncological control. Notably, his 2024 study on the effects of thienopyridine-class antiplatelets on bleeding outcomes—cited 7 times—provides critical guidance for managing patients on these medications during RARP. Complementing this, his investigation into the effects of aging on surgical complications (7 citations) offers essential insights for treating an increasingly elderly patient population. Negoro has also made pivotal contributions to the debate on extended lymph node dissection, reevaluating its therapeutic role in the RARP era, and has explored the benefits of neurovascular bundle preservation for high-risk patients. His work extends to neoadjuvant chemohormonal therapy for very high-risk cases and a rare case report on CO₂ embolism during robotic partial nephrectomy, demonstrating his breadth in advancing safe, effective robotic urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6